{
    "ticker": "NEOV",
    "name": "Neovasc Inc.",
    "description": "Neovasc Inc. is a medical device company focused on developing innovative products for the cardiovascular market. Founded in 2000 and headquartered in Vancouver, Canada, Neovasc aims to address unmet needs in the treatment of heart disease. The company is best known for its flagship product, the Neovasc Reducer, which is designed to treat refractory angina, a chronic and debilitating condition caused by reduced blood flow to the heart. The Reducer is a unique device that is implanted in the coronary venous system, creating a controlled ischemia that decreases angina symptoms. In addition to the Reducer, Neovasc is developing its Tiara transcatheter mitral valve replacement system, which aims to provide an innovative solution for patients suffering from mitral valve disease. Neovasc is committed to advancing the field of cardiovascular treatment through rigorous clinical research and development. The company has a robust pipeline of products that leverage its proprietary technologies. With a focus on improving patient outcomes and quality of life, Neovasc is at the forefront of transforming cardiovascular care.",
    "industry": [
        "Medical Devices",
        "Healthcare"
    ],
    "headquarters": "Vancouver, Canada",
    "founded": "2000",
    "website": "https://www.neovasc.com",
    "ceo": "Fred Colen",
    "social_media": {
        "twitter": "https://twitter.com/neovasc",
        "linkedin": "https://www.linkedin.com/company/neovasc/"
    },
    "investor_relations": "https://www.neovasc.com/investors/",
    "key_executives": [
        {
            "name": "Fred Colen",
            "position": "CEO"
        },
        {
            "name": "David S. H. R. M. K. Sergey",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Cardiovascular Devices",
            "products": [
                "Neovasc Reducer",
                "Tiara"
            ]
        }
    ],
    "seo": {
        "meta_title": "Neovasc Inc. | Innovative Cardiovascular Solutions",
        "meta_description": "Learn about Neovasc Inc., a leading company in cardiovascular medical devices. Discover their innovative products aimed at treating heart disease.",
        "keywords": [
            "Neovasc",
            "Cardiovascular Devices",
            "Medical Innovation",
            "Heart Disease Treatment",
            "Neovasc Reducer",
            "Tiara"
        ]
    },
    "faq": [
        {
            "question": "What is Neovasc known for?",
            "answer": "Neovasc is known for its innovative cardiovascular devices, particularly the Neovasc Reducer and the Tiara transcatheter mitral valve."
        },
        {
            "question": "Who is the CEO of Neovasc?",
            "answer": "Fred Colen is the CEO of Neovasc Inc."
        },
        {
            "question": "Where is Neovasc headquartered?",
            "answer": "Neovasc is headquartered in Vancouver, Canada."
        },
        {
            "question": "What are Neovasc's main products?",
            "answer": "Neovasc's main products include the Neovasc Reducer and the Tiara transcatheter mitral valve replacement system."
        },
        {
            "question": "When was Neovasc founded?",
            "answer": "Neovasc was founded in 2000."
        }
    ],
    "competitors": [
        "MDT",
        "ABT",
        "SYK",
        "ZBH"
    ],
    "related_stocks": [
        "AAPL",
        "JNJ",
        "PFE",
        "UNH"
    ]
}